Exela Takes Alphagan Patent Ruling To Fed. Circ.
Exela PharmSci Pvt. And Exela Pharm Sci. Inc. filed a notice of appeal in the U.S. District Court for the District of Delaware on Thursday, saying they were appealing the trial court’s Oct. 23 order to the U.S. Court of Appeals for the Federal Circuit.
But Exela’s appeal isn’t just taking aim at that order. The Exela...
To view the full article, register now.